Advances in the development of a targeted N-Terminal Domain androgen receptor (AR) degrader (ANITAC) for the treatment of prostate cancer

N.H. Hong,B. Biannic, P. Virsik, H.J. Zhou,R. Le Moigne

European Journal of Cancer(2022)

引用 0|浏览1
暂无评分
关键词
prostate cancer,degrader,n-terminal
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要